AF
ABCL icon

Allworth Financial’s AbCellera Biologics ABCL Stock Holding History

Allworth Financial’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.8K Buy
15,401
+4,127
+37% +$14.8K ﹤0.01% 2268
2025
Q4 		$38.6K Buy
11,274
+10,096
+857% +$45.1K ﹤0.01% 2371
2025
Q3 		$5.93K Buy
1,178
+207
+21% +$912 ﹤0.01% 3455
2025
Q2 		$3.33K Buy
971
+69
+8% +$172 ﹤0.01% 3478
2025
Q1 		$2.35K Sell
902
-380
-30% -$1.09K ﹤0.01% 3145
2024
Q4 		$4.53K Buy
1,282
+931
+265% +$2.59K ﹤0.01% 2810
2024
Q3 		$913 Buy
+351
New +$973 ﹤0.01% 3251
2023
Q4 		– Sell
-335
Closed -$1.54K – 3448
2023
Q3 		$1.54K Buy
335
+290
+644% +$1.76K ﹤0.01% 2667
2023
Q2 		$291 Buy
+45
New +$307 ﹤0.01% 3026

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return